The results demonstrated with ST101 in this GBM study are very encouraging, given the poor prognosis associated with this brain cancer. With the data presented at #ASCO24 today, we believe that ST101 has the potential to be a well-tolerated treatment option for patients, and we look forward to its continued development in combination Phase 2 studies. #ASCO2024 #oncology #GBM
Sapience Therapeutics, Inc.’s Post
More Relevant Posts
-
5-α Reductase Inhibitors and Prostate Cancer Mortality: A Population-Based Cohort Study in Canada Julian Chavarriaga Cindy Lau Maria Komisarenko Christopher Wallis https://lnkd.in/e5vnVUys #AdvancedProstateCancer #APCCC #Cancer #CancerResearch #JAMANetworkOpen #OncoDaily #Oncology #ProstateCancer
-
-
The ArteraAI, Prostate Cancer Test can now inform active surveillance treatment decisions for low-risk patient - Andre Esteva, PhD PathNet National Comprehensive Cancer Network® (NCCN®) https://lnkd.in/eyu7BtEB #Cancer #OncoDaily #Oncology #PathNetLab #ProstateCancer
-
-
https://lnkd.in/eTkdZe8q Panel discussion and review of SABCS 2023 Breast Cancer data and its impact on clinical practice moderated by Dr. Rami J. Younan featuring Dr. Julie Lemieux & Dr. Kim Ma. #cancerresearch #breastcancer #breastcancerresearch #oncology #oncologyresearch #oncologytrials #cancertherapy #breastcancertreatment #cancerdusein #clinicaltrials #metastaticbreastcancer #her2 Groupe McPeak-Sirois de recherche clinique en cancer du sein
-
-
https://lnkd.in/en3stgFh Watch Dr. Carlos A. Gonzalez Nuñez discuss 'De-escalation studies: The Next Step in Early Breast Cancer' in this brief video from the ASCO Meeting #cancerresearch #breastcancer #breastcancerresearch #oncology #oncologyresearch #oncologytrials #cancertherapy #breastcancertreatment #cancerdusein #clinicaltrials #metastaticbreastcancer #her2 #ASCO2024 #precisionmedicine #oncologist Groupe McPeak-Sirois de recherche clinique en cancer du sein
-
Oncological and functional outcome after laryngectomy for laryngeal and hypopharyngeal cancer: a population-based analysis in Germany from 2001 to 2020 https://lnkd.in/edg4MpJC 🔪 #SurgicalOncology #SurgOnc #Oncology #Cancer
-
-
According to Gomez-Iturriaga, MD, PhD, Brachytherapy can be offered to almost all patients with localized prostate cancer. “Specifically, we target individuals with intermediate to high-risk disease for maximum benefits from the precision and intensity of brachytherapy doses.” Learn more about patient selection. https://lnkd.in/gx4-5cxx #Brachytherapy #Radonc #Brachytherapy #Prostatecancer #Oncology
-
March is Colon Cancer Awareness Month. Let us add more attention to raise Awareness of Colon Cancer and the importance of cancer screening for early detection. #Cancer #coloncancerawareness #MOLDCARE #oncology #radiationoncology #radiationtherapy #radiotherapy
-
-
According to Gomez-Iturriaga, MD, PhD, Brachytherapy can be offered to almost all patients with localized prostate cancer. “Specifically, we target individuals with intermediate to high-risk disease for maximum benefits from the precision and intensity of brachytherapy doses.” Learn more about patient selection. https://lnkd.in/eY_V-vy3 #Brachytherapy #Radonc #Brachytherapy #Prostatecancer #Oncology
-
February is National Cancer Prevention Month. For those with a brain cancer diagnosis, whether a primary tumor or a tumor that metastasized to the brain—see if GammaTile might be a treatment option for you, learn more about GammaTile® : https://shorturl.at/FKNWZ #cancerawarenessmonth #braincancer #braintumor #oncology #medtech #GammaTile
-
https://lnkd.in/ewqFWC6w Dr. Erika P. Hamilton shared an exciting update on the overall survival data from the DESTINY-Breast03 trial. The findings bring fantastic news for patients with HER2+ breast cancer, showing an impressive improvement in survival by approximately 10 months. #cancerresearch #breastcancer #breastcancerresearch #oncology #oncologyresearch #oncologytrials #cancertherapy #breastcancertreatment #cancerdusein #clinicaltrials #metastaticbreastcancer #her2 #ASCO2024 #precisionmedicine #oncologist Groupe McPeak-Sirois de recherche clinique en cancer du sein
-
